 Pharmacologic treatment noncognitive behavioral disturbances elderly demented patients Fifty-nine elderly residents long-term care facilities DSM-III diagnoses dementia randomized double-blind comparison trial haloperidol oxazepam diphenhydramine efficacy agents treatment significant behavioral disturbances patients dementia agents demonstrated modest significant efficacy clinician ratings agitated behavior activities daily living absolute magnitude improvement haloperidol diphenhydramine oxazepam differences groups statistical significance Frequencies acute adverse events trial similar drug treatment groups drugs terms long-term safety efficacy equivalent short-term management agitated behavior demented patients